These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33872044)

  • 1. SARS-CoV-2 Reinfection in a Liver Transplant Recipient.
    Tomkins-Tinch CH; Daly JS; Gladden-Young A; Theodoropoulos NM; Madaio MP; Yu N; Vanguri VK; Siddle KJ; Adams G; Krasilnikova LA; Movahedi B; Bozorgzadeh A; Simin K; Lemieux JE; Luban J; Park DJ; MacInnis BL; Sabeti PC; Levitz SM
    Ann Intern Med; 2021 Aug; 174(8):1178-1180. PubMed ID: 33872044
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.
    Serrano OK; Kutzler HL; Rochon C; Radojevic JA; Lawlor MT; Hammond JA; Gluck J; Feingold AD; Jaiswal A
    Transpl Infect Dis; 2020 Dec; 22(6):e13367. PubMed ID: 32533615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 in an HIV-positive kidney transplant recipient.
    Kumar RN; Tanna SD; Shetty AA; Stosor V
    Transpl Infect Dis; 2020 Oct; 22(5):e13338. PubMed ID: 32453483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome.
    Hayashi K; Ito Y; Yamane R; Yoshizaki M; Matsushita K; Kajikawa G; Kozawa T; Mizutani T; Shimizu Y; Nagano K; Tachi K; Yoshioka K; Goto H
    Clin J Gastroenterol; 2021 Jun; 14(3):842-845. PubMed ID: 33675512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019 infection in kidney transplant recipients: A clinical case series.
    Asgharpour M; Afshar ZM; Ebrahimpour S; Babazadeh A; Oladzad S
    Saudi J Kidney Dis Transpl; 2021; 32(2):579-583. PubMed ID: 35017357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.
    Tang CY; Wang Y; McElroy JA; Li T; Hammer R; Ritter D; Lidl GM; Webby R; Hang J; Wan XF
    J Med Virol; 2021 Oct; 93(10):5700-5703. PubMed ID: 34170528
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience of SARS-CoV-2 infection in two kidney transplant recipients living with HIV-1 infection.
    Chowdary P; Shetty S; Booth J; Khurram MA; Yaqoob M; Mohamed IH
    Transpl Infect Dis; 2021 Apr; 23(2):e13500. PubMed ID: 33174284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of COVID-19 disease in immunosuppressed renal transplant patients.
    Dheir H; Sipahi S; Yaylacı S; Çetin ES; Genç AB; Fırat N; Köroğlu M; Muratdağı G; Tomak Y; Özmen K; Ateş ÖF; Karabay O
    Turk J Med Sci; 2021 Apr; 51(2):428-434. PubMed ID: 33185367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.
    Song KH; Kim DM; Lee H; Ham SY; Oh SM; Jeong H; Jung J; Kang CK; Park JY; Kang YM; Kim JY; Park JS; Park KU; Kim ES; Kim HB
    Korean J Intern Med; 2021 Jan; 36(1):11-14. PubMed ID: 32972123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow Recovery from Critical Coronavirus Disease 2019 Pneumonia in an Immunosuppressed Renal Transplant Recipient with Early Acute Cardiorenal Syndrome.
    Zhu L; Shu H; Li H; Qiu T; Zhou J; Chen G
    Cardiorenal Med; 2020; 10(6):470-475. PubMed ID: 32987381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
    Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
    Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19.
    Roedl K; Heidenreich S; Pfefferle S; Jarczak D; Urbanowicz TT; Nörz D; Aepfelbacher M; Kröger N; Kluge S; Lütgehetmann M; Christopeit M; Wichmann D
    Am J Respir Crit Care Med; 2021 Jan; 203(2):242-245. PubMed ID: 33253054
    [No Abstract]   [Full Text] [Related]  

  • 13. Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus?
    García-Juárez I; Campos-Murguía A; Tovar-Méndez VH; Gabutti A; Ruiz I
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(4):437-442. PubMed ID: 33032841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anosmia: A Clinical Indicator of COVID-19 Reinfection.
    Jain A; Kaur J; Rai AK; Pandey AK
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):180S-181S. PubMed ID: 33295221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 re-infection: Diagnostic challenges and proposed diagnostic criteria.
    Raveendran AV
    Diabetes Metab Syndr; 2021; 15(2):645-648. PubMed ID: 33663969
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2.
    Ünsal O; Yazıcı O; Özdemir N; Çubukçu E; Ocak B; Üner A; Özet A
    Future Oncol; 2022 Feb; 18(5):533-541. PubMed ID: 34825831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis.
    Rodríguez-Espinosa D; Broseta Monzó JJ; Casals Q; Piñeiro GJ; Rodas L; Vera M; Maduell F
    J Nephrol; 2021 Aug; 34(4):1041-1043. PubMed ID: 34097293
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-erythropoietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus.
    Schecter JM; Mears JG; Alobeid B; Gaglio PJ
    Liver Transpl; 2007 Nov; 13(11):1589-92. PubMed ID: 17969182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid reinfection of severe acute respiratory syndrome coronavirus 2 confirmed with sequencing in a solid organ transplant recipient.
    Natori Y; Andrews D; Guerra G
    Transpl Infect Dis; 2022 Jun; 24(3):e13840. PubMed ID: 35467066
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients.
    Zilla ML; Keetch C; Mitchell G; McBreen J; Shurin MR; Wheeler SE
    J Appl Lab Med; 2021 Mar; 6(2):486-490. PubMed ID: 33367709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.